|
Bioethic information and analysis newsletter |
|||
|
|
Previous Letter |
|
|
|
N°35 - November 2002 |
|||
|
ADN : a programmed language Freedom Selection of humans The genetic Quotient 1 - Charles Richet,
In a hundred years, La Revue scientifique, March 1892 |
|
Belgium authorises euthanasia, an isolated case facing Europe ? |
|
A Belgian doctor practising euthanasia does not commit any offence if he fulfils the request of an adult patient, expressed
"voluntarily, deliberately and repeatedly".
What is the European position ? First of all remember what was said at the Nuremberg trials at the end of World War 2, the Court adopted the Nuremberg Code, which supplements the Hippocratic
Oath. It defines the fundamental code of practice governing experimentation on
humans. No doubt it was the memory of this recent history which prompted the Parliamentary Assembly of the Council of Europe to adopt in June 1999,
Recommendation 1418 : « Protection of Human Rights and the dignity of incurably ill and dying
patients ». The European organisations involved in this thinking were particularly keen to preserve the balance between abiding by the Hippocratic Oath and remaining open to modern questions, a balance which covers most of the positions adopted on this question by the medical profession. The conclusion is
a categorical rejection of euthanasia, for reasons which are made obvious by end of life care, with its
despair, its fears, its false requests. |
|
The adoption of the law depenalising euthanasia in Belgium, coincided with the all-important decree by the European Court for Human Rights in the Pretty case versus the United Kingdom (29th April 2002). The 43-year old applicant, suffering from the terminal phase of amyotrophic lateral sclerosis, wished to put an end to her days. Being completely paralysed, she obtained a promise from her husband to help her to commit suicide. However, such help contravenes English law. Mrs Pretty asked for a waiver, which was rejected. She therefore turned to the European Court for Human Rights, considering that the English law contravenes in particular (and essentially) articles 2 (rights to live) and 3 (prohibition of inhuman and degrading treatments), 8 (right to respect for private and family life), 9 (freedom of thought, conscience and religion), and 14 (non-discrimination). The crux of her claim concerned articles 2 and 3, which are part of the hard core of Human Rights (which cannot be subject to any waiver). We shall discuss here only the response by the Court concerning the alleged violation of article 2. Mrs Pretty claims that this measure « guarantees not only the right to live, but also the right to choose to continue or to cease to live ». In other words, article 2 covers not only a positive right (the right to live), but also includes a negative right (that of refusing to live). The Court replied by stating that «
among the measures in the Convention which it judges essential, {it}, in its precedent, grants precedence to article
2. » Indeed, « article 2 protects the right to live, without which the possession of any of the other rights and liberties guaranteed by the Convention would be illusory ». In all its precedence,
the Court has always stressed the obligation of the State to protect
life. The absolute nature of this article was then recalled : « It has no relationship with questions concerning the quality of life or what a person may choose to do with their life ». Very interestingly,
the Court referred to Resolution 1418 of the European Parliamentary Council Assembly, which follows the logic and fundamental objectives of the
Convention for Safeguarding of Rights and fundamental Liberties : « The Assembly recommends (…) the Committee of Ministers to encourage the European Council member States to respect and protect the dignity of incurable and terminally sick patients in all circumstances (…)
by maintaining the absolute prohibition to intentionally end the lives of the incurably and terminally sick : Resolution 1418 has thus made its entry into European
precedent.
|
is a monthly newsletter, distributed free of charge, and published by the Jérôme Lejeune Foundation.
Director of the Publication and Editor in chief : Jean-Marie Le Méné
Contact : Aude Dugast - 31 rue Galande - 75005 Paris - France - Tel : +33 (0)1.55.42.55.14
- ISSN 1638-198 X
contact@genethique.org
|
|
|
|